2022
DOI: 10.1016/j.mri.2022.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic resonance imaging in patients with cardiac implantable electronic devices: A prospective study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…3.2 μT as previously suggested in the FPO:B) might used for untested implants under the assumption that its safe (e.g. cardiac pacemakers as suggested in current literature (Sohns and Sommer 2021, Nazarian et al 2017, Navarro-Valverde et al 2022). From table 4, it is easy to see that applying a fixed + B 1 strategy will lead to a more conservative exposure compared to normal operating mode (e.g.…”
Section: Discussionmentioning
confidence: 90%
“…3.2 μT as previously suggested in the FPO:B) might used for untested implants under the assumption that its safe (e.g. cardiac pacemakers as suggested in current literature (Sohns and Sommer 2021, Nazarian et al 2017, Navarro-Valverde et al 2022). From table 4, it is easy to see that applying a fixed + B 1 strategy will lead to a more conservative exposure compared to normal operating mode (e.g.…”
Section: Discussionmentioning
confidence: 90%
“…In such a case, disturbances due to EMF noise mainly concern universal non-ionizing procedures using MRI. The second category concerns body onboard embedded and wearable devices [14][15][16][17][18].…”
Section: Introductionmentioning
confidence: 99%
“…The wearable biosensors involved behave as non-intrusive tools allowing real-time monitoring of patients, providing sufficient data to establish their health status and can constitute a first diagnosis. Devices integrated into the body can be static passive for permanent monitoring, e.g., [17], or active stimulating or assisting tools, e.g., [18]. All of these onboard tools enable diligent, personalized and tailored healthcare.…”
Section: Introductionmentioning
confidence: 99%